van den Boom Esther 4
4 · Tyra Biosciences, Inc. · Filed Nov 4, 2021
Insider Transaction Report
Form 4
van den Boom Esther
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-11-02+83,626→ 83,626 totalExercise: $24.15Exp: 2031-11-01→ Common Stock (83,626 underlying) - Award
Stock Option (Right to Buy)
2021-11-02+7,964→ 7,964 totalExercise: $24.15Exp: 2031-11-01→ Common Stock (7,964 underlying) - Award
Stock Option (Right to Buy)
2021-11-02+7,964→ 7,964 totalExercise: $24.15Exp: 2031-11-01→ Common Stock (7,964 underlying)
Footnotes (2)
- [F1]1/48th of the shares subject to the option vest monthly following November 2, 2021, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.
- [F2]The option vests based on achievement of a performance objective.